Literature DB >> 26513502

Pathological Effects of Mutant C1QTNF5 (S163R) Expression in Murine Retinal Pigment Epithelium.

Astra Dinculescu, Seok-Hong Min, Frank M Dyka, Wen-Tao Deng, Rachel M Stupay, Vince Chiodo, W Clay Smith, William W Hauswirth.   

Abstract

PURPOSE: The mutation S163R in complement C1q tumor necrosis factor-related protein-5 (C1QTNF5) causes an autosomal dominant disorder known as late-onset retinal degeneration (L-ORD). In this study, our goal is to evaluate the consequences of mutant S163R C1QTNF5 expression in mouse RPE following its delivery using an adeno-associated viral (AAV) vector.
METHODS: We generated AAV vectors containing either human wild-type C1QTNF5 or mutant S163R C1QTNF5 driven by an RPE-specific BEST1 promoter, and delivered them subretinally into one eye of adult C57BL/6 mice. Transgene expression was detected by immunohistochemistry. Retinal function was assessed by full-field ERG. Pathological changes were further examined by digital fundus imaging and spectral-domain optical coherence tomography (SD-OCT).
RESULTS: We show that the AAV-expressed mutant S163R leads to pathological effects similar to some of those found in patients with advanced L-ORD, including RPE thinning, RPE cell loss, and retinal degeneration. In addition, we provide in vivo evidence that mutant S163R C1QTNF5 can form large, transparent, spherical intracellular aggregates throughout the RPE, which are detectable by light microscopy. In contrast to AAV-expressed wild-type C1QTNF5, which is secreted apically from the RPE toward the photoreceptor cells and the outer limiting membrane, the S163R mutant is primarily routed toward the basal side of RPE, where it forms thick, extracellular deposits over time.
CONCLUSIONS: Adeno-associated viral-targeted expression of mutant S163R in the RPE represents a useful approach for quickly generating animal models that mimic pathological features of L-ORD and offers the potential to understand disease mechanisms and develop therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26513502      PMCID: PMC4627469          DOI: 10.1167/iovs.15-17166

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  61 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina.

Authors:  Hilda Petrs-Silva; Astra Dinculescu; Qiuhong Li; Wen-Tao Deng; Ji-Jing Pang; Seok-Hong Min; Vince Chiodo; Andy W Neeley; Lakshmanan Govindasamy; Antonette Bennett; Mavis Agbandje-McKenna; Li Zhong; Baozheng Li; Giridhara R Jayandharan; Arun Srivastava; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

3.  A CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration.

Authors:  Venkata R M Chavali; Naheed W Khan; Catherine A Cukras; Dirk-Uwe Bartsch; Monica M Jablonski; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2011-02-24       Impact factor: 6.150

4.  Functional and morphological analysis of the subretinal injection of retinal pigment epithelium cells.

Authors:  Maren Engelhardt; Chinatsu Tosha; Vanda S Lopes; Bryan Chen; Lisa Nguyen; Steven Nusinowitz; David S Williams
Journal:  Vis Neurosci       Date:  2012-03-06       Impact factor: 3.241

5.  Silencing the expression of CTRP5/C1QTNF5 and ELOVL4 genes by small interfering RNA.

Authors:  Venkata Ramana Murthy Chavali; Vidyullatha Vasireddy; Radha Ayyagari
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5.

Authors:  Xinhua Shu; Brian Tulloch; Alan Lennon; Dafni Vlachantoni; Xinzhi Zhou; Caroline Hayward; Alan F Wright
Journal:  Hum Mol Genet       Date:  2006-04-06       Impact factor: 6.150

7.  Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.

Authors:  Kurt R Weiss; Yoko Kimura; Wyan-Ching Mimi Lee; J Troy Littleton
Journal:  Genetics       Date:  2011-11-17       Impact factor: 4.562

8.  A detailed phenotypic assessment of individuals affected by MFRP-related oculopathy.

Authors:  Rajarshi Mukhopadhyay; Panagiotis I Sergouniotis; Donna S Mackay; Alexander C Day; Genevieve Wright; Sophie Devery; Bart P Leroy; Anthony G Robson; Graham E Holder; Zheng Li; Andrew R Webster
Journal:  Mol Vis       Date:  2010-03-26       Impact factor: 2.367

Review 9.  The dynamic nature of Bruch's membrane.

Authors:  J C Booij; D C Baas; J Beisekeeva; T G M F Gorgels; A A B Bergen
Journal:  Prog Retin Eye Res       Date:  2009-09-10       Impact factor: 21.198

10.  Characterisation of a C1qtnf5 Ser163Arg knock-in mouse model of late-onset retinal macular degeneration.

Authors:  Xinhua Shu; Ulrich F O Luhmann; Tomas S Aleman; Susan E Barker; Alan Lennon; Brian Tulloch; Mei Chen; Heping Xu; Samuel G Jacobson; Robin Ali; Alan F Wright
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

View more
  10 in total

1.  Potential participation of CTRP6, a complement regulator, in the pathology of age related macular degeneration.

Authors:  Katsuhiko Shinomiya; Atsushi Mukai; Eiko Ito; Kazuhito Yoneda; Morio Ueno; Chie Sotozono; Shigeru Kinoshita; Junji Hamuro
Journal:  Jpn J Ophthalmol       Date:  2022-04-09       Impact factor: 2.447

2.  Loss of CTRP5 improves insulin action and hepatic steatosis.

Authors:  Xia Lei; Susana Rodriguez; Pia S Petersen; Marcus M Seldin; Caitlyn E Bowman; Michael J Wolfgang; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-03       Impact factor: 4.310

3.  Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration.

Authors:  Chloe M Stanton; Shyamanga Borooah; Camilla Drake; Joseph A Marsh; Susan Campbell; Alan Lennon; Dinesh C Soares; Neeru A Vallabh; Jayashree Sahni; Artur V Cideciyan; Baljean Dhillon; Veronique Vitart; Samuel G Jacobson; Alan F Wright; Caroline Hayward
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

4.  Autosomal Dominant Gyrate Atrophy-Like Choroidal Dystrophy Revisited: 45 Years Follow-Up and Association with a Novel C1QTNF5 Missense Variant.

Authors:  Ulrich Kellner; Nicole Weisschuh; Silke Weinitz; Ghazaleh Farmand; Sebastian Deutsch; Friederike Kortüm; Pascale Mazzola; Karin Schäferhoff; Valerio Marino; Daniele Dell'Orco
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

5.  Biometrics, Impact, and Significance of Basal Linear Deposit and Subretinal Drusenoid Deposit in Age-Related Macular Degeneration.

Authors:  Ling Chen; Jeffrey D Messinger; Deepayan Kar; Jacque L Duncan; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

Review 6.  Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models.

Authors:  Michael Landowski; Catherine Bowes Rickman
Journal:  J Ocul Pharmacol Ther       Date:  2021-11-17       Impact factor: 2.671

7.  AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration.

Authors:  Kiyoharu J Miyagishima; Ruchi Sharma; Malika Nimmagadda; Katharina Clore-Gronenborn; Zoya Qureshy; Davide Ortolan; Devika Bose; Mitra Farnoodian; Congxiao Zhang; Andrew Fausey; Yuri V Sergeev; Mones Abu-Asab; Bokkyoo Jun; Khanh V Do; Marie-Audrey Kautzman Guerin; Jorgelina Calandria; Aman George; Bin Guan; Qin Wan; Rachel C Sharp; Catherine Cukras; Paul A Sieving; Robert B Hufnagel; Nicolas G Bazan; Kathleen Boesze-Battaglia; Sheldon Miller; Kapil Bharti
Journal:  Commun Biol       Date:  2021-12-09

Review 8.  Antecedents of Soft Drusen, the Specific Deposits of Age-Related Macular Degeneration, in the Biology of Human Macula.

Authors:  Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-20       Impact factor: 4.799

Review 9.  Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies.

Authors:  Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-20       Impact factor: 4.799

10.  Late-onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1.

Authors:  Anil Chekuri; Katarzyna Zientara-Rytter; Angel Soto-Hermida; Shyamanga Borooah; Marina Voronchikhina; Pooja Biswas; Virender Kumar; David Goodsell; Caroline Hayward; Peter Shaw; Chloe Stanton; Donita Garland; Suresh Subramani; Radha Ayyagari
Journal:  Aging Cell       Date:  2019-08-05       Impact factor: 9.304

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.